IP Library Assignment 039083/0386
Patent Assignment
Reel/Frame 039083/0386

Assignment of Assignor's Interest

Recorded: 2016-07-06 Pages: 10
Assignor
TABUTEAU, HERRIOT
Executed: 2016-06-14
Assignee
ANTECIP BIOVENTURES II LLC
630 FIFTH AVENUE, SUITE 2000, NEW YORK, NEW YORK, 10111
Covered Properties (15)
Compositions and Methods of Using Threohydroxybupropion for Therapeutic Purposes
Patent: 9,402,843 →
Application: 14/602,177 →
Publication: US US20150133485A1
Bupropion as a Modulator of Drug Activity
Patent: 9,168,234 →
Application: 14/604,397 →
Publication: US US20150133486A1
Hydroxybupropion and Related Compounds as Modulators of Drug Plasma Levels
Patent: 9,486,450 →
Application: 14/617,624 →
Publication: US US20150150830A1
Methods for the Safe Administration of Imidazole or Imidazolium Compounds
Patent: 9,427,403 →
Application: 14/625,457 →
Publication: US US20150157564A1
Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
Patent: 9,283,239 →
Application: 14/635,857 →
Publication: US US20150164929A1
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Low Back Pain
Patent: 9,408,860 →
Application: 14/686,551 →
Publication: US US20150216884A1
Compositions Comprising Rank/Rankl Antagonists and Related Compounds for Treating Pain
Patent: 9,205,045 →
Application: 14/812,989 →
Publication: US US20150359736A1
Bupropion as a Modulator of Drug Activity
Patent: 9,278,095 →
Application: 14/863,284 →
Publication: US US20160008352A1
Compositions and Methods for Increasing Dextromethorphan Plasma Levels and Related Pharmacodynamic Effects
Patent: 9,314,462 →
Application: 14/878,998 →
Publication: US US20160030420A1
Compositions and Methods Comprising Celecoxib or Related Compounds and Dextromethorphan
Application: 14/878,980 →
Publication: US US20160038464A1
Compositions and Methods Comprising Erythrohydroxybupropion and Related Compounds for Improving the Efficacy of Dextromethorphan
Patent: 9,375,429 →
Application: 14/879,002 →
Publication: US US20160030421A1
Osteoclast Inhibitors for Knee Conditions
Patent: 9,408,861 →
Application: 14/967,224 →
Publication: US US20160095871A1
Osteoclast Inhibitors for Knee Conditions
Patent: 9,511,081 →
Application: 14/967,234 →
Publication: US US20160113950A1
Therapeutic Compositions Comprising Imidazole and Imidazolium Compounds
Patent: 9,408,862 →
Application: 14/968,514 →
Publication: US US20160095872A1
Compositions and Methods Comprising Bupropion or Related Compounds for Sustained Delivery of Dextromethorphan
Patent: 9,457,025 →
Application: 14/997,316 →
Publication: US US20160128998A1
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 11, 2015
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 034939/0893 →
Assignment of Assignor's Interest Jul 6, 2015
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 035980/0996 →
Assignment of Assignor's Interest Aug 31, 2015
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 036462/0471 →
Assignment of Assignor's Interest Sep 22, 2015
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 036620/0738 →
Assignment of Assignor's Interest Dec 8, 2015
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 037237/0135 →
Assignment of Assignor's Interest Mar 15, 2016
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 037979/0154 →
Assignment of Assignor's Interest May 18, 2016
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 038632/0271 →